Myovant Sciences Ltd.
MYOV
MYOV was delisted on the 9th of March, 2023.
2 hedge funds and large institutions have $27 invested in Myovant Sciences Ltd. in 2023 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 116 closing their positions.
98% less funds holding
Funds holding: 118 → 2 (-116)
100% less funds holding in top 10
Funds holding in top 10: 8 → 0 (-8)
100% less capital invested
Capital invested by funds: $1.12B → $27 (-$1.12B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 116
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity International
Hamilton,
Bermuda
|
-$233M |
| 2 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$159M |
| 3 |
State Street
Boston,
Massachusetts
|
-$78.5M |
| 4 |
Goldman Sachs
New York
|
-$65.3M |
| 5 |
CC
Carlson Capital
Dallas,
Texas
|
-$48.7M |
MYOV Hedge Fund Activity: Q1 2023 in Review
2 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Myovant Sciences Ltd. (MYOV) for Q1 2023, worth a combined $27 — down 100% from $1.12B a quarter earlier.
Sellers outnumbered buyers: 116 funds closed out of MYOV and 0 opened new positions — a net loss of 116 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity International, exiting entirely with an estimated $233M sold.
- 2 institutional investors held Myovant Sciences Ltd. (MYOV) as of Q1 2023, down from 118 in Q4 2022.
- Funds reported $27 of Myovant Sciences Ltd. stock for Q1 2023, down 100% quarter-over-quarter.
- 0 funds opened new Myovant Sciences Ltd. positions in Q1 2023 and 116 closed out, a net change of -116 holders.
- The largest Myovant Sciences Ltd. seller in Q1 2023 was Fidelity International, an estimated $233M sold.
Based on aggregated 13F filings for Q1 2023.